Scott K Dessain

This inventor holds 6 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Lankenau Institute for Medical Research, Thomas Jefferson University, Whitehead Institute for Biomedical Research. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott K Dessain. Retrieved from https://idiyas.com/inventor/scott-k-dessain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

3 out of 32

Lankenau Institute for Medical Research

patents

2 out of 539

Thomas Jefferson University

patents

1 out of 319

Whitehead Institute for Biomedical Research

patents

Years Active: 2009-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12715935 - METHODS AND COMPOSITIONS FOR INDUCIBLE EXTRACELLULAR MEMBRANE CAPTURE OF MONOCLONAL IMMUNOGLOBULINS SECRETED BY HYBRIDOMAS (2026-08-25),

2. 12221484 - Anti-NMDA receptor antibodies and methods of use (2025-02-11),

3. 11946074 - Methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas (2024-04-02),

4. 8999707 - Method of making hybrid cells that express useful antibodies (2015-04-07),

5. 8557575 - Fusion partner cell line for preparation of hybrid cells expressing human antibodies (2013-10-15),

6. 7491530 - Fusion partner cells and uses thereof (2009-02-17),

Title: Scott K Dessain: Innovator in Antibody Research

Introduction

Scott K Dessain is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of antibody research, holding a total of five patents. His work focuses on innovative methods and compositions that advance the understanding and application of antibodies in medical diagnostics and therapeutics.

Latest Patents

Among his latest patents is the development of anti-NMDA receptor antibodies and methods of use. This patent describes a recombinant, synthetic, or monoclonal human antibody that binds to an N-methyl-D-aspartate receptor (NMDAR) epitope. The antibody comprises at least one heavy chain variable domain sequence that is at least 80% identical to specific sequences. Additionally, he has developed methods and compositions for inducible extracellular membrane capture of monoclonal immunoglobulins secreted by hybridomas. This innovation allows for the identification and characterization of target proteins through a unique Anchor-Linker complex.

Career Highlights

Scott K Dessain has worked with esteemed institutions such as Thomas Jefferson University and the Lankenau Institute for Medical Research. His career is marked by a commitment to advancing medical research through innovative antibody technologies.

Collaborations

He has collaborated with notable colleagues, including Sharad P Adekar and Robert Allan Weinberg, contributing to a rich environment of scientific inquiry and discovery.

Conclusion

Scott K Dessain's work exemplifies the intersection of innovation and medical research, particularly in the field of antibody development. His contributions continue to influence the landscape of biomedical science and diagnostics.

Profile summary based on public USPTO records.